Vaxxinity, Inc. (VAXX)
OTCMKTS
· Delayed Price · Currency is USD
0.0200
+0.0199 (19,900.00%)
Apr 28, 2026, 4:00 PM EST
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $12.68 thousand as of April 29, 2026.
Market Cap
12.68K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 12.68K, a decrease of -100.00%. That is a compound annual growth rate of -93.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 12.68K | -66.67% |
| Dec 31, 2025 | 38.02K | -94.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marizyme | 132.00 |
| PsyBio Therapeutics | 133.00 |
| Seelos Therapeutics | 136.00 |
| NexImmune | 139.00 |
| RVL Pharmaceuticals | 111.00 |
| Kiromic BioPharma | 157.00 |
| Infinity Pharmaceuticals | 91.00 |
| American Oriental Bioengineering | 88.00 |